Dnadvent Lifesciences Private Limited, a active private limited company, was established on 16 December 2016 in Hyderabad, Telangana, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U85300TG2016PTC113450. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.14 M.
It upholds a compliant status. Its leadership includes Kousthubh Kumar Thatipamula (Director), Parre Basava Rao (Director), Karthik Kumar Tatipamula (Director). Past directors included Krishna Chary Nagaram. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat 103, Sri Rama Residency, H-2-93/10, Kondapur, Hyderabad, Telangana, 500081.
U85300TG2016PTC113450
113450
16 December 2016
₹1.00 M
₹0.14 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Dnadvent Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kousthubh Kumar Thatipamula | Director | 16 Dec 2016 | Current |
| Parre Basava Rao | Director | 16 Dec 2016 | Current |
| Karthik Kumar Tatipamula | Director | 16 Dec 2016 | Current |
| Krishna Chary Nagaram | Director | 27 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dnadvent Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 55.09% decrease. The company also saw a substantial fall in profitability, with a 86.82% decrease in profit. The company's net worth Soared by an impressive increase of 24.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Dnadvent Lifesciences had a promoter holding of 86.03% and a public holding of 13.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dnadvent Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dnadvent Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dnadvent Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dnadvent Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Dnadvent Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Krishna Chary Nagaram was appointed as a Director was appointed as a Director on 27 Jul 2017 & has been associated with this company since 8 years 4 months . was recorded as a recent event.
The activity Kousthubh Kumar Thatipamula was appointed as a Director was appointed as a Director on 16 Dec 2016 & has been associated with this company since 8 years 11 months . was completed.
Progress on Parre Basava Rao was appointed as a Director was appointed as a Director on 16 Dec 2016 & has been associated with this company since 8 years 11 months . was documented.
The activity Karthik Kumar Tatipamula was appointed as a Director was appointed as a Director on 16 Dec 2016 & has been associated with this company since 8 years 11 months . was completed.
The CIN of Dnadvent Lifesciences Private Limited is U85300TG2016PTC113450.
Dnadvent Lifesciences Private Limited is headquartered at Flat 103, Sri Rama Residency, H-2-93/10, Kondapur, Hyderabad, Telangana, 500081.
Dnadvent Lifesciences Private Limited was incorporated on 16 December 2016.
The current directors of Dnadvent Lifesciences Private Limited are
The primary industry of Dnadvent Lifesciences Private Limited is Professional, Scientific And Technical.
Dnadvent Lifesciences Private Limited is unlisted.
The authorized capital of Dnadvent Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.14 M.
The compliance status of Dnadvent Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX